From the Journal

Biolimus-A9 Eluting Stent Implantion for Unprotected Left Main Coronary Artery Stenosis: 9-Month Strut Coverage as Assessed by Optical Coherence Tomography

Nevio Taglieri, MD;  Gabriele Ghetti, MD;  Francesco Saia, MD, PhD;  Carolina Moretti, MD;  Pamela Gallo, MD;  

Gianni Dall’Ara;  Tullio Palmerini, MD;  Cinzia Marrozzini, MD;  Claudio Rapezzi, MD;  Antonio Marzocchi, MD

Incomplete stent strut coverage is a risk factor for late stent thrombosis. This study evaluates strut coverage after biolimus-A9 eluting stent (BES) implantation for unprotected left main artery (ULMA) stenosis during follow-up and identify features associated with the length of uncovered stent segment. ...

Prevalence and Treatment of “Balloon-Uncrossable” Coronary Chronic Total Occlusions

Siddharth M. Patel, BS;  Nagendra R. Pokala, BS;  Rohan V. Menon, BS;  Anna P. Kotsia, MD;  Vijay Raja, MD; 

George Christopoulos, MD;  Tesfaldet T. Michael, MD, MPH;  Bavana V. Rangan, BDS, MPH;  Daniel Sherbet, MD; 

Vishal G. Patel, MD;  Shuaib A. Abdullah, MD;  Jeffrey Hastings, MD;  Jerrold M. Grodin, MD; 

Subhash Banerjee, MD;  Emmanouil S. Brilakis, MD, PhD

We retrospectively examined 373 consecutive CTO-PCIs performed at our institution between 2005 and 2013 to determine the frequency and treatment of balloon-uncrossable CTOs. Balloon-uncrossable CTOs are encountered in 6.4% of contemporary CTO-PCIs and can be successfully treated in most patients using a variety of techniques....

Bioresorbable Vascular Scaffold Thrombosis in an All-Comer Patient Population: Single-Center Experience

Lorenzo Azzalini, MD, MSc and Philippe L. L’Allier, MD


Experience with bioresorbable vascular scaffolds (BVSs) outside clinical trials is scarce, and data from “real-world” use are needed. In particular, there are few data on scaffold thrombosis (ST); we report our experience with ST in our allcomer BVS population (n = 339) and review the literature on the topic. ...

Percutaneous Extracorporeal Life Support in Patients With Circulatory Failure: Results of the German Lifebridge Registry

Christian Jung, MD1;  Marcus Franz, MD1;  Hans-Rainer Figulla, MD1;  Steffen Sonntag, MD2;  Martin Hug, MD3

Harald Mudra, MD3;  Robert Bauerschmitt, MD4;  Franz-Xaver Kleber, MD5;  Peter Feindt, MD6

Uwe Mehlhorn, MD7;  Christian Vahl, MD7;  Hans-Juergen Bruns, PhD8;  Markus Ferrari, MD9


Mortality rates remain high in patients with cardiogenic shock or acute refractory circulatory failure. This study evaluates the procedural performance and safety of the automated Lifebridge extracorporeal life support system (Zoll Lifebridge GmbH)....

Back to top